Literature DB >> 12795339

Genetics of alcohol and tobacco use in humans.

Rachel F Tyndale1.   

Abstract

The field of genetics holds great promise for furthering our understanding of the etiology of drug dependence and for identifying novel targets for treatment. Genetic studies utilizing twins and families have demonstrated a considerable role for genetics in nicotine and/or alcohol dependence. Risk for alcoholism or nicotine dependence is likely to be the result of a large number of genes, each contributing a small fraction of the overall risk. While this review will focus on studies in humans, many of the candidate genes for human nicotine and alcohol dependence listed here were originally postulated to be important, based on data from animal studies. The review will briefly summarize the results from twin and adoption studies that provide estimations of heritability, the results from chromosomal linkage studies that identify regions of chromosomes that may contain relevant genes, and the results of candidate gene studies. For each topic the data will be presented for nicotine dependence, alcohol dependence, and for nicotine and alcohol dependence together. In addition, each section will review briefly some of the confounding issues in the specific type of approach utilized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795339     DOI: 10.1080/07853890310010014

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  70 in total

1.  Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.

Authors:  J O'Loughlin; G Paradis; W Kim; J DiFranza; G Meshefedjian; E McMillan-Davey; S Wong; J Hanley; R F Tyndale
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

Review 2.  The genetics of nicotine dependence.

Authors:  Ming D Li
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

3.  Elevated Behavioral Economic Demand for Alcohol in a Community Sample of Heavy Drinking Smokers.

Authors:  Michael Amlung; James MacKillop; Peter M Monti; Robert Miranda
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

4.  Sequence variations of the human MPDZ gene and association with alcoholism in subjects with European ancestry.

Authors:  Victor M Karpyak; Jeong-Hyun Kim; Joanna M Biernacka; Eric D Wieben; David A Mrazek; John L Black; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2009-01-21       Impact factor: 3.455

5.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

Review 6.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 7.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 8.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

9.  Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence.

Authors:  Joke Beuten; Jennie Z Ma; Thomas J Payne; Randolph T Dupont; Karen M Crews; Grant Somes; Nancy J Williams; Robert C Elston; Ming D Li
Journal:  Am J Hum Genet       Date:  2005-03-09       Impact factor: 11.025

10.  Associations and interactions between SNPs in the alcohol metabolizing genes and alcoholism phenotypes in European Americans.

Authors:  Richard Sherva; John P Rice; Rosalind J Neuman; Nanette Rochberg; Nancy L Saccone; Laura J Bierut
Journal:  Alcohol Clin Exp Res       Date:  2009-03-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.